Table 4.
Comparison of the endpoint events in patients who achieved the target control (HbA1c, blood pressure, LDL-C, and the joint target control) >3 times and <3 times.
| Clinical characteristics | n | All-cause death | Coronary heart disease | Cerebrovascular disease | Stenosis or occlusion of large arteries | Diabetic microvascular complications | Malignant tumor |
|---|---|---|---|---|---|---|---|
| Target control in blood pressure | |||||||
| ≥3 times | 150 | 9 (6.00) | 13 (8.67) | 14 (9.33) | 4 (2.67) | 18 (12.00) | 6 (4.00) |
| <3 times | 74 | 14 (18.92) | 5 (6.76) | 6 (8.11) | 6 (8.11) | 7 (9.46) | 9 (12.16) |
| χ 2 | 13.49 | 0.01 | 0.21 | 7.93 | 0.11 | 6.86 | |
| P | 0.00 | 0.92 | 0.65 | 0.01 | 0.75 | 0.01 | |
|
| |||||||
| Target control in HbA1c | |||||||
| ≥3 times | 144 | 10 (6.94) | 10 (6.94) | 9 (6.25) | 3 (2.08) | 13 (9.03) | 7 (4.86) |
| <3 times | 80 | 13 (16.25) | 8 (10.00) | 11 (13.75) | 7 (8.75) | 12 (15.00) | 8 (10.00) |
| χ 2 | 7.77 | 2.04 | 7.17 | 9.65 | 4.39 | 3.21 | |
| P | 0.01 | 0.15 | 0.01 | 0.00 | 0.04 | 0.07 | |
|
| |||||||
| Target control in LDL-C | |||||||
| ≥3 times | 104 | 7 (6.73) | 10 (9.62) | 8 (7.69) | 4 (3.85) | 10 (9.62) | 4 (3.85) |
| <3 times | 120 | 16 (13.33) | 8 (6.67) | 12 (10.00) | 6 (5.00) | 15 (12.50) | 11 (9.17) |
| χ 2 | 4.9 | 0.06 | 2.24 | 1.34 | 2.15 | 3.7 | |
| P | 0.03 | 0.81 | 0.13 | 0.25 | 0.14 | 0.06 | |
|
| |||||||
| Joint target control | |||||||
| ≥3 times | 61 | 1 (1.64) | 6 (9.84) | 0 (0.00) | 0 (0.00) | 3 (4.92) | 1 (1.64) |
| <3 times | 163 | 22 (13.50) | 12 (7.36) | 20 (12.27) | 10 (6.13) | 22 (13.50) | 14 (8.59) |
| χ 2 | 8.63 | 0 | 11.35 | 6.15 | 5.66 | 4.12 | |
| P | 0.00 | 0.96 | 0.00 | 0.01 | 0.02 | 0.04 | |